Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
AS03
Description:
AS03 is an oil-in-water emulsion vaccine adjuvant containing squalene, used to enhance immune responses to vaccines.
Primary topic:
Influenza Virus Research Studies (38%)
Related topics:
Influenza Virus Research Studies (38%),
Immunotherapy and Immune Responses (30%),
SARS-CoV-2 and COVID-19 Research (8%)
Wikidata ID:
wiki/Q297156
OpenAlex ID:
keywords/as03
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
2018
·
Giuseppe Del Giudice
, Rino Rappuoli
, et al.
·
Seminars in Immunology
·
672
PDF
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
2019
·
Shuting Shi
, Haoru Zhu
, et al.
·
Vaccine
·
467
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
2021
·
Brian J. Ward
, Philipe Gobeil
, et al.
·
Nature Medicine
·
394
PDF
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
2012
·
Nathalie Garçon
, David W Vaughn
, et al.
·
Expert Review of Vaccines
·
384
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
2021
·
Prabhu S. Arunachalam
, Alexandra C. Walls
, et al.
·
Nature
·
337
PDF
Adjuvanted influenza vaccines
2018
·
John S. Tregoning
, Ryan F. Russell
, et al.
·
Human Vaccines & Immunotherapeutics
·
293
PDF
Characterization of Antibody Responses Elicited by Human Immunodeficiency Virus Type 1 Primary Isolate Trimeric and Monomeric Envelope Glycoproteins in Selected Adjuvants
2006
·
Y. Li
, K. Svehla
, et al.
·
Journal of Virology
·
175
AS03- and MF59-Adjuvanted Influenza Vaccines in Children
2017
·
Amanda L. Wilkins
, Dmitri Kazmin
, et al.
·
Frontiers in Immunology
·
167
PDF
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
2017
·
Wivine Burny
, Andrea Callegaro
, et al.
·
Frontiers in Immunology
·
160
PDF
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants
2013
·
Christopher B Fox
, Jean Haensler
·
Expert Review of Vaccines
·
154
“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
2021
·
Derek T. O’Hagan
, Robbert van der Most
, et al.
·
npj Vaccines
·
138
PDF
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
2022
·
Etsuro Nanishi
, Francesco Borriello
, et al.
·
Science Translational Medicine
·
130
On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives
2015
·
Paolo Pellegrino
, Emilio Clementi
, et al.
·
Autoimmunity Reviews
·
125
Developments in Vaccine Adjuvants
2021
·
Farrhana Ziana Firdaus
, Mariusz Skwarczynski
, et al.
·
Methods in molecular biology
·
122
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
2021
·
Paul A Goepfert
, Bo Fu
, et al.
·
The Lancet Infectious Diseases
·
121
PDF
From Sharks to Yeasts: Squalene in the Development of Vaccine Adjuvants
2022
·
Adélia Mendes
, João Azevedo-Silva
, et al.
·
Pharmaceuticals
·
98
PDF
Adjuvant strategies to improve vaccination of the elderly population
2018
·
Birgit Weinberger
·
Current Opinion in Pharmacology
·
94
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice
2013
·
Sofia E. Magnusson
, Jenny M. Reimer
, et al.
·
Vaccine
·
88
Inactivated and Adjuvanted Influenza Vaccines
2014
·
Giuseppe Del Giudice
, Rino Rappuoli
·
Current topics in microbiology and immunology
·
86
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine
2011
·
Paolo Durando
, Rocco Iudici
, et al.
·
Human Vaccines
·
81
PDF
Adjuvants for Pandemic Influenza Vaccines
2009
·
Robert L. Atmar
, Wendy A. Keitel
·
Current topics in microbiology and immunology
·
81
Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response
2021
·
Phuong Nguyen-Contant
, Mark Y. Sangster
, et al.
·
Pathogens
·
79
PDF
Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood
2019
·
Béatrice Laupèze
, Caroline Hervé
, et al.
·
Vaccine
·
75
PDF
Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus
2024
·
Surender Khurana
, Lisa R. King
, et al.
·
Nature Medicine
·
71
Age-Specific Effectiveness of an Oil-in-Water Adjuvanted Pandemic (H1N1) 2009 Vaccine Against Confirmed Infection in High Risk Groups in England
2010
·
N. Andrews
, P. Waight
, et al.
·
The Journal of Infectious Diseases
·
70
PDF
Show more works
View as search
Works count:
129
Citation count:
6,261
Year
Topic
Type